Menu
CB Medical Courier Services Review of Guangzhou Galen Biotech Co., Ltd
Guangzhou Galen Biotech Co., Ltd

Guangzhou Galen Biotech Co., Ltd review: Exposing unethical business practices by Guangzhou Galen Biotech Co., Ltd.

S
Author of the review
5:42 am EDT
Verified customer This complaint was posted by a verified customer. Learn more
Featured review
This review was chosen algorithmically as the most valued customer feedback.

Dear Community,

We are a India-based company that has unfortunately fallen victim to the deceptive business practices of Guangzhou Galen Biotech Co., Ltd.

In February 2023, we diligently fulfilled our end of the agreement by delivering goods totaling USD 82,500.00 to Guangzhou Galen Biotech Co., Ltd. However, despite receiving the goods, they have failed to honor their payment obligations, resulting in substantial financial losses for our company. Despite numerous attempts to resolve the matter amicably, they have consistently refused to fulfill their financial commitments.

The actions of Guangzhou Galen Biotech Co., Ltd. not only showcase a blatant disregard for ethical business conduct but also indicate a pattern of deceitful behavior in commercial transactions. We have been left with no choice but to pursue legal action against them to seek the justice and restitution we rightfully deserve.

This public disclosure serves as a warning to others in the business community about the unscrupulous practices of Guangzhou Galen Biotech Co., Ltd. It is our hope that by shedding light on their dishonest behavior, we can prevent potential victims from falling prey to similar deceitful tactics. We urge fellow businesses to exercise caution and vigilance when engaging with Guangzhou Galen Biotech Co., Ltd. and offer our full support to those who may have also been affected by their actions.

Sincerely

Confidential Information Hidden: This section contains confidential information visible to verified company representatives only. If you are affiliated with company, please claim your business to access these details.

0 comments
Add a comment